Trial Profile
Phase II trial of PBT434 in patients with atypical Parkinsonian disease
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 09 Jul 2019
Price :
$35
*
At a glance
- Drugs ATH 434 (Primary)
- Indications Parkinson's disease
- Focus Therapeutic Use
- 01 Mar 2016 New trial record